-+ 0.00%
-+ 0.00%
-+ 0.00%
CAREDX ANNOUNCES NEW KOAR DATA LINKING ELEVATED ALLOSURE® KIDNEY TO NEARLY 3-FOLD HIGHER RISK OF ADVERSE GRAFT OUTCOMES IN PATIENTS WITH BORDERLINE REJECTION OR TCMR AT ASN KIDNEY WEEK 2026
Share

Please log in to view news

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending